Abdominal obesity is associated with increased worsening renal function risk in patients with heart failure with preserved ejection fraction
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Abdominal obesity is associated with increased worsening renal function risk in patients with heart failure with preserved ejection fraction ; volume:24 ; number:1 ; day:9 ; month:9 ; year:2024 ; pages:1-10 ; date:12.2024
BMC cardiovascular disorders ; 24, Heft 1 (9.9.2024), 1-10, 12.2024
- Creator
-
Zhang, Quan
Tai, Shi
Zhou, Shenghua
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12872-024-04118-0
- URN
-
urn:nbn:de:101:1-2411232102369.503910930212
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhang, Quan
- Tai, Shi
- Zhou, Shenghua
- SpringerLink (Online service)
Other Objects (12)
Worsening effect of testosterone deficiency on males with heart failure with preserved ejection fraction
Comorbidities in heart failure with preserved ejection fraction
Biomarkers in heart failure with preserved ejection fraction
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Animal models of heart failure with preserved ejection fraction
Heart Failure with Preserved Ejection Fraction—a Concise Review
Gender-related differences in heart failure with preserved ejection fraction
133 Obesity is associated with decreased myocardial contraction fraction despite preserved ejection fraction
Diastolic dysfunction in individuals with and without heart failure with preserved ejection fraction
Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Worsening effect of testosterone deficiency on males with heart failure with preserved ejection fraction
Comorbidities in heart failure with preserved ejection fraction
Biomarkers in heart failure with preserved ejection fraction
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Animal models of heart failure with preserved ejection fraction
Heart Failure with Preserved Ejection Fraction—a Concise Review
Gender-related differences in heart failure with preserved ejection fraction
133 Obesity is associated with decreased myocardial contraction fraction despite preserved ejection fraction
Diastolic dysfunction in individuals with and without heart failure with preserved ejection fraction
Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Worsening effect of testosterone deficiency on males with heart failure with preserved ejection fraction
Comorbidities in heart failure with preserved ejection fraction
Biomarkers in heart failure with preserved ejection fraction
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Animal models of heart failure with preserved ejection fraction
Heart Failure with Preserved Ejection Fraction—a Concise Review
Gender-related differences in heart failure with preserved ejection fraction
133 Obesity is associated with decreased myocardial contraction fraction despite preserved ejection fraction
Diastolic dysfunction in individuals with and without heart failure with preserved ejection fraction
Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment